Enanta hits new highs as Leerink gets bullish

|About: Enanta Pharmaceuticals, Inc. (ENTA)|By:, SA News Editor

Shares of Enanta (ENTA +6.7%) are hitting new highs today on above average volume.

Helping the cause is Leerink, where analysts have upgraded the shares to Outperform.

Price target is $29.

See also: AbbVie reports SAPPHIRE-1 HCV results.